Literature DB >> 9523775

Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases.

P Gallien1, S Robineau, B Nicolas, M P Le Bot, R Brissot, M Verin.   

Abstract

OBJECTIVE: Vesicourethral dysfunction is common in people with multiple sclerosis and results in significant impairment. We studied the clinical and urodynamic findings in such patients to define risk factors for incontinence and upper urinary tract infections. DESIGN AND
SETTING: A cohort study of 149 patients with multiple sclerosis and urinary symptoms seen in our urodynamic laboratory. INTERVENTION: A complete urodynamic study of each patient with urethrocystometry and continuous recording of the urethral sphincter electromyography and assessment of postvoid residual.
RESULTS: Detrusor hyperreflexia and sphincter dyssynergia were the main dysfunctions. No significant relation between clinical features and urodynamic patterns was found. Women with low maximal urethral pressure were particularly prone to incontinence, which occurred in 69% of the patients. Pyelonephritis was associated with a postvoiding residual urine of > 30% of the functional detrusor capacity, and was found more often in the male population.
CONCLUSION: Urodynamic assessment of bladder function is critical to direct therapy for urinary complaints in people with multiple sclerosis.

Entities:  

Mesh:

Year:  1998        PMID: 9523775     DOI: 10.1016/s0003-9993(98)90003-x

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  11 in total

Review 1.  Underactive Bladder.

Authors:  Himanshu Aggarwal; Philippe E Zimmern
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

Review 2.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

3.  Effects of pregnancy and child birth on urinary symptoms and urodynamics in women with multiple sclerosis.

Authors:  Aurélie Durufle; Sabine Petrilli; Benoit Nicolas; Sandrine Robineau; François Guillé; Gilles Edan; Philippe Gallien
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-05

4.  Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.

Authors:  P Gallien; J-M Reymann; G Amarenco; B Nicolas; M de Sèze; E Bellissant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

5.  Videourodynamics in patients with neurogenic bladder due to multiple sclerosis: our experience.

Authors:  D Caramella; G Donatelli; N Armillotta; F Manassero; C Traversi; P Frumento; D Pistolesi; C Selli
Journal:  Radiol Med       Date:  2011-01-12       Impact factor: 3.469

6.  Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.

Authors:  E Castel-Lacanal; X Gamé; X De Boissezon; J Guillotreau; E Braley-Berthoumieux; C Terracol; D Gasq; M Labrunee; F Viala; P Rischmann; M Clanet; P Marque
Journal:  World J Urol       Date:  2013-01-06       Impact factor: 4.226

Review 7.  Management of neurogenic bladder in patients with multiple sclerosis.

Authors:  Véronique Phé; Emmanuel Chartier-Kastler; Jalesh N Panicker
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

8.  THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.

Authors:  Giorgia Teresa Maniscalco; R Aponte; D Bruzzese; G Guarcello; V Manzo; M Napolitano; O Moreggia; F Chiariello; C Florio
Journal:  Neurol Sci       Date:  2017-10-19       Impact factor: 3.307

Review 9.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

10.  Bladder Dysfunction in Iranian Patients with Multiple Sclerosis.

Authors:  Mohaddeseh Azadvari; Seyede Zahra Emami Razavi; Masumeh Shahrooei; Abdorreza Naser Moghadasi; Amirreza Azimi; Hamid Reza Farhadi-Shabestari
Journal:  J Multidiscip Healthc       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.